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Specific pathways mediating 
inflammasome activation by 
Candida parapsilosis
Adél Tóth1,*, Erik Zajta1,*, Katalin Csonka1, Csaba Vágvölgyi1, Mihai G. Netea2 & Attila Gácser1
Candida albicans and C. parapsilosis are human pathogens causing severe infections. The NLRP3 
inflammasome plays a crucial role in host defence against C. albicans, but it has been previously 
unknown whether C. parapsilosis activates this complex. Here we show that C. parapsilosis induces 
caspase-1 activation and interleukin-1β (IL-1β) secretion in THP-1, as well as primary, human 
macrophages. IL-1β secretion was dependent on NLRP3, K+-efflux, TLR4, IRAK, Syk, caspase-1, 
caspase-8 and NADPH-oxidase. Importantly, while C. albicans induced robust IL-1β release after 4 h, 
C. parapsilosis was not able to stimulate the production of IL-1β after this short incubation period. We 
also found that C. parapsilosis was phagocytosed to a lesser extent, and induced significantly lower 
ROS production and lysosomal cathepsin B release compared to C. albicans, suggesting that the low 
extent of inflammasome activation by C. parapsilosis may result from a delay in the so-called “signal 
2”. In conclusion, this is the first study to examine the molecular pathways responsible for the IL-1β 
production in response to a non-albicans Candida species, and these results enhance our understanding 
about the immune response against C. parapsilosis.
Invasive fungal infections pose a serious health problem worldwide, particularly amongst immunocompromised 
patients1. Candida species are the most common cause of life-threatening disseminated fungal infections in crit-
ically ill patients (e.g. those who are severely immunocompromised and/or have undergone invasive procedures 
or major trauma)1. Despite the availability of antifungal drugs, the mortality associated with these infections 
is unacceptably high (25–40%)2. Although C. albicans remains the most common etiological agent of invasive 
candidiasis, the incidence of non-albicans Candida (NAC) spp. has been on the rise3. Despite this, host defence 
mechanisms against the NAC species is poorly understood, although evidence is emerging on the differences in 
immune response induced by C. albicans and other Candida spp.4–8.
C. parapsilosis is one of the most clinically relevant NAC species, being responsible for 17.1% of invasive 
Candida infections worldwide9. Newborns are especially susceptible to C. parapsilosis infection: 33.47% of neona-
tal Candida infections are caused by this species10. It is perplexing that C. parapsilosis causes such a large number 
of human infections despite being considerably less virulent than C. albicans in vitro and in animal models11,12. 
Understanding how the immune response is modulated during C. parapsilosis infection may explain this paradox, 
and ultimately lead to the development of novel, immune-based antifungal therapies.
Interleukin-1β (IL-1β ) is one of the most important mediators of inflammation and acute phase response, 
and also contributes to the differentiation of Th17 cells, shaping adaptive immune responses13–15. In monocytes 
and macrophages, IL-1β is first produced in an inactive precursor form which is subsequently processed to 
its biologically active form by caspase-1, a component of a multiprotein complex called the inflammasome16. 
The best characterized NLRP3 inflammasome consists of NLRP3 (NLR Family, Pyrin Domain Containing 3), 
a two-domain adaptor protein called ASC, and pro-caspase-113. The activation of the NLRP3 inflammasome 
is a two-step process: firstly, “signal 1” – that is typically delivered by pattern recognition receptors – initiates 
both IL1B gene transcription as well as the priming of the inflammasome by up-regulating NLRP3 mRNA and 
triggering post-translational changes in the NLRP3 protein, and secondly, “signal 2” induces the activation of 
the complex17. This so-called “signal 2” step of inflammasome activation can be stimulated by many different 
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agonists, such as particulate materials, ATP or pore-forming toxins. All activators induce cationic fluxes, ROS 
accumulation, and/or lysosomal damage and inhibition of these cellular events prevents caspase-1 activation17.
The importance of inflammasome activation and IL-1β secretion during C. albicans infection is highlighted 
by the findings that mice deficient in IL-1β receptor or inflammasome components NLRP3, ASC or CASPASE1 
are highly susceptible to disseminated candidiasis14,18. Furthermore, inflammasome activation triggered by 
C. albicans infection can lead to pyroptosis in macrophages. It is a proinflammatory form of programmed cell 
death mediated by caspase-1 activation and characterized by the loss of cell integrity19,20. Inflammasome activa-
tion by C. albicans is dependent on recognition by specific PRRs, such as Dectin-1 and TLR214, as well as ROS 
production, K+-efflux and lysosomal rupture21,22. Importantly, inflammasome activation is also necessary for 
the processing of IL-18, another pro-inflammatory cytokine that plays an important role in the activation of Th1 
lymphocytes23.
Although the role of inflammasome activation in immunity against C. albicans infection has been well estab-
lished, little is known about its role in host defence against NAC species. C. parapsilosis induces the transcription 
of pro-IL-1β and the production of IL-1β in human macrophages7,24, but the signalling pathways leading to IL-1β 
secretion have not been investigated yet.
Here we used PMA-induced THP-1 as well as primary human macrophages to characterize the molecular 
background of IL-1β production in response to C. parapsilosis infection. This is the first study describing the 
details of inflammasome activation by a NAC species, and our results also provide new insights about the inflam-
matory response induced by C. albicans.
Results
C. parapsilosis activates the NLRP3 inflammasome in THP-1 cells and primary human macrophages. 
First, we stimulated PMA-differentiated THP-1 macrophages for 24 h with different doses of C. parapsilosis cells 
and measured the amount of secreted IL-1β in cell culture supernatants. We found that live but not heat-inac-
tivated C. parapsilosis induced the secretion of IL-1β in a dose-dependent manner (Fig. 1a and Fig. S1a). To 
Figure 1. C. parapsilosis induces caspase-dependent IL-1β release in human macrophages. THP-1 
macrophages or human MDMs were stimulated with C. parapsilosis or C. albicans and the concentration of 
secreted IL-1β (in cell culture supernatants) or intracellular pro-IL-β (in cell lysates) was determined by ELISA 
or Western blot (cropped). (a,b) THP-1 macrophages were stimulated with C. parapsilosis at different MOIs for 
24 h (a) or at MOI 5 for the indicated incubation periods (b). (c,d) THP-1 macrophages were stimulated with C. 
parapsilosis or C. albicans at MOI 0.01 for 24 h (c) or at MOI 5 for 4 h (d). (e) MDMs were co-incubated with C. 
parapsilosis at MOI 5 for 24 h. (f) THP-1 macrophages or MDMs were stimulated with C. parapsilosis at MOI 5 
for 24 h. (g,h) THP-1 macrophages (g) or MDMs (h) were stimulated with C. parapsilosis (MOI 5, 24 h)  
or C. albicans (MOI 0.04, 24 h) in the presence or absence of pan-caspase inhibitor Z-VAD-FMK (10 μ M). 
IL-1β production is expressed as % of control (IL-1β secretion measured in cells stimulated with Candida 
spp + vehicle). Results (mean ± SEM) are pooled data from at least three (a,c,d,e,g,h) or representative of two 
(b,f) independent experiments. Ctrl, control (medium-treated cells); Ca, C. albicans; Cp, C. parapsilosis; sup, 
supernatants; lys, cell lysates; MOI, multiplicity of infection. *p < 0.05, ***p < 0.001 (compared to control) as 
determined by paired t-test.
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determine the kinetics of IL-1β secretion, we stimulated THP-1 macrophages with live C. parapsilosis (MOI 5) 
and examined the production of IL-1β at different intervals post-infection. We found that at least a 12-hour 
incubation period was required for C. parapsilosis to induce IL-1β release (Fig. 1b). Since C. albicans is a potent 
inducer of IL-1β in THP-1 cells25, we also stimulated THP-1 macrophages with C. albicans and found that this 
species induced a robust IL-1β production by 4 h incubation at an MOI of 5 (Fig. 1d). Notably, even a very low 
amount (MOI 0.01) of C. albicans cells was sufficient to induce IL-1β secretion in THP-1 cells after 24 h incuba-
tion (Fig. 1c).
As a result of PMA-treatment, pro-IL-1β protein is already abundant in THP-1 cells. To assess whether 
C. parapsilosis can induce the synthesis of pro-IL-1β and the release of the mature cytokine in primary cells, we 
stimulated human monocyte-derived macrophages (MDMs) with C. parapsilosis (MOI 5) and measured their 
cytokine production. We found that at 24 h incubation, C. parapsilosis induced the production of pro-IL-1β and 
the release of IL-1β in MDMs as well (Fig. 1e,f). IL-18 production was also induced upon 24 h stimulation with 
C. parapsilosis, in both THP-1 cells and human MDMs (Fig. S1b,c).
As IL-1β can also be processed by alternative mechanisms, we wanted to examine whether the production 
of IL-1β upon C. parapsilosis infection is a result of caspase activation. To this end, we stimulated THP-1 and 
primary human macrophages with C. parapsilosis for 24 h in the presence or absence of the pan-caspase inhib-
itor Z-VAD-FMK. We found that THP-1 macrophages (Fig. 1g) and MDMs (Fig. 1h) treated with the inhib-
itor secreted significantly less IL-1β following stimulation with C. parapsilosis, while the level of intracellular 
pro-IL-1β remained largely unaffected (data not shown). As expected, inhibition of caspase activity also decreased 
the production of IL-1β in response to C. albicans stimulation (Fig. 1g,h).
To examine whether C. parapsilosis is able to directly activate the inflammasome, we assessed the activa-
tion of caspase-1 in host cells in response to C. parapsilosis stimulation using a fluorescence-based assay. THP-1 
macrophages as well as MDMs stimulated with C. parapsilosis for 24 h showed significantly increased caspase-1 
Figure 2. C. parapsilosis activates the NLRP3 inflammasome. (a–d) THP-1 macrophages (a,b) or human 
MDMs (c,d) were stimulated with C. parapsilosis (MOI 5) for 24 h and caspase-1 activation was assessed by flow 
cytometry using the FAM-FLICA caspase-1 assay. (b–d) Values are expressed as MFI fold change compared to 
unstained samples. (e,f) THP-1 macrophages (control, ASC-deficient or NLRP3-deficient) were stimulated with 
C. parapsilosis (MOI 5) or C. albicans (MOI 0.04) for 24 h and secreted IL-1β or pro-IL-β were determined by 
Western blot (cropped) (e) or ELISA (f). (g) THP-1 macrophages were stimulated with C. parapsilosis (MOI 5)  
or C. albicans (MOI 0.04) for 24 h in the presence of 50 mM KCl and the concentration of secreted IL-1β was 
determined by ELISA. Cytokine levels are expressed as % of control values (cytokine levels of vehicle treated 
samples). Results (mean ± SEM) are pooled data from (b,d,f,g) or representative of (a,c,e) at least three 
independent experiments. Ctrl, control (medium-treated cells); Ca, C. albicans; Cp, C. parapsilosis; MFI, median 
fluorescence intensity. *p < 0.05, **p < 0.01, *** p < 0.001 (compared to control) as determined by paired (b,d,g) 
or unpaired (f) t-test.
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activity compared to medium-control cells, indicating the activation of the inflammasome (Fig. 2a–d). As an 
additional control, we measured the activity of caspase-1 in C. albicans-stimulated cells, which showed a sim-
ilar response (data not shown). To confirm that C. parapsilosis activates the NLRP3 inflammasome, we stimu-
lated THP-1 macrophages deficient in inflammasome components (ASC and NLRP3) with C. parapsilosis cells 
and assessed their IL-1β production by ELISA and Western blot. IL-1β was barely detectable in these cell lines, 
indicating that both C. parapsilosis and C. albicans induce NLRP3 inflammasome-dependent IL-1β production 
(Fig. 2e,f). IL-18 production was also diminished in ASC- and NLRP3-deficient THP-1 cells upon C. parapsilosis 
or C. albicans stimulation (Fig. S1d).
Induction of K+ efflux is a requirement for NLRP3 inflammasome activation by many agonists, including C. 
albicans21,25. To examine whether decreased intracellular K+ concentration is also necessary for the induction 
of IL-1β release by C. parapsilosis, we examined the production of IL-1β following the blockade of K+-efflux by 
50 mM KCl. Inhibition of K+-efflux dramatically decreased the secretion of IL-1β in response to C. parapsilosis 
and C. albicans infection (Fig. 2g). In conclusion, these results demonstrate that C. parapsilosis is able to induce 
NLRP3 inflammasome-dependent cytokine production in human macrophages.
C. parapsilosis-induced IL-1β production is dependent on TLR2, TLR4, IRAK, Syk, caspase-8 
and NADPH-oxidase in THP-1 macrophages. After confirming that IL-1β production induced by C. 
parapsilosis is NLRP3-dependent, we wanted to examine whether the same molecular pathways are involved in 
inflammasome activation upon C. parapsilosis and C. albicans stimulation. To investigate the role of TLR2, TLR4, 
IRAK, Syk, caspase-8 and NADPH-oxidase in C. parapsilosis-induced IL-1β production, we used chemical inhib-
itors in our experimental system, and measured the concentration of intracellular pro-IL-1β and released IL-1β 
by ELISA. We found that IL-1β secretion induced by C. parapsilosis and C. albicans was strongly dependent on 
TLR4, Syk, caspase-8 and NADPH-oxidase, while TLR2 and IRAK seemed to have a minor role in IL-1β release 
(Fig. 3a). While the inhibition of TLR2 and IRAK did not affect, and TLR4 as well as caspase-8 inhibition only 
slightly decreased the level of intracellular pro-IL-1β upon C. parapsilosis or C. albicans stimulation, blocking 
of Syk or NADPH-oxidase strongly reduced the amount of pro-IL-1β (Fig. 3b). Interestingly, the reduction in 
pro-IL-1β levels upon Syk inhibition was more profound in response to C. albicans infection. Taken together, 
these results show that TLR2, TLR4, IRAK, Syk, caspase-8 and NADPH-oxidase are involved in the induction of 
Figure 3. C. paraspilosis induces inflammasome activation by a similar mechanism as C. albicans. THP-1 
macrophages were stimulated with C. parapsilosis (MOI 5) or C. albicans (MOI 0.04) for 24 h in the presence or 
absence of specific inhibitors (TLR2 mAb, 0.15 μ g/ml; TLR4 inhibitor CLI-095, 5 μ M; IRAK inhibitor 509093-
47-4, 5 μ M; Syk inhibitor ER 27319 maleate, 5 μ M; caspase-8 inhibitor Z-IETD-FMK, 10 μ M; NADPH-oxidase 
inhibitor apocynin, 600 μ M). Secreted IL-1β was determined in cell culture supernatants by ELISA (a) and 
pro-IL-1β was measured by ELISA following the lysis of THP-1 cells by repeated freeze-thaw cycles (b). Results 
(mean ± SEM) are pooled data from at least three independent experiments. Ca, C. albicans; Cp, C. parapsilosis. 
*p < 0.05, **p < 0.01, ***p < 0.001 (compared to control) as determined by paired t-test. Cytokine levels are 
expressed as % of control values (cytokine levels of vehicle treated samples).
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IL-1β production in response to both C. albicans and C. parapsilosis in THP-1 macrophages, but Syk activation 
may be differentially regulated upon C. parapsilosis and C. albicans infection.
The lack of signal 2 results in delayed inflammasome activation upon C. parapsilosis stimu-
lation. Next, we wanted to examine why C. parapsilosis requires long co-incubation periods to induce 
inflammasome activation in host cells. As mentioned previously, C. albicans induced high IL-1β levels in THP-1 
macrophages after 4 h (Fig. 1d). However, C. parapsilosis did not induce the secretion of IL-1β after 4 h incubation, 
even when a MOI of 10 was used (data not shown). Similarly, in contrast to C. albicans, C. parapsilosis could not 
induce the release of IL-1β at a low MOI after 24 h (Fig. 1c). To examine if this marked difference in IL-1β produc-
tion is species-specific, we stimulated THP-1 macrophages with different isolates of C. parapsilosis and C. albicans 
for 24 h and measured their IL-1β production. We found that none of the C. parapsilosis strains was able to induce 
IL-1β release when added in a low dose (MOI 0.02), while all of them triggered similar levels of IL-1β at MOI 5 
(Fig. 4a). In contrast, all of the C. albicans strains induced significant IL-1β production at a MOI of 0.02 (Fig. S1e).
Although pro-IL-1β is already upregulated in THP-1 macrophages following PMA-treatment, we wanted to 
examine whether stimulation with Candida spp. results in a further increase in its level. We found that while C. 
parapsilosis did not induce pro-IL-1β upregulation after 4 h, stimulation with C. albicans significantly increased its 
accumulation (Fig. 4b). On the other hand, IL-1β could not be detected in the supernatants of MDMs following 
Figure 4. The lack of signal 2 results in delayed inflammasome activation upon C. parapsilosis stimulation. 
(a) THP-1 macrophages were stimulated with different C. parapsilosis strains at MOI 0.02 or MOI 5 for 24 h and 
secreted IL-1β was determined in cell culture supernatants by ELISA. (b) THP-1 macrophages were stimulated 
with C. parapsilosis or C. albicans at MOI 5 for 4 h and the amount of intracellular pro-IL-1β was measured 
by ELISA. (c,d) Human MDMs were stimulated with C. parapsilosis or C. albicans at MOI 5 for 4 h and the 
amount of secreted IL-1β or intracellular pro-IL-1β was determined by ELISA. (e,g) THP-1 macrophages were 
stimulated with C. parapsilosis or C. albicans at MOI 1 for 4 h. Intracellular ROS was determined by DCFDA 
assay (e), cathepsin B release was measured by a fluorometric cathepsin B activity assay kit (g). (f) THP-1 
macrophages were stimulated with C. parapsilosis or C. albicans at MOI 5 for 4 h in the presence or absence of 
phagocytosis inhibitor cytochalasin D (2.5 μ M) and the amount of secreted IL-1β was determined by ELISA. 
(h) THP-1 macrophages were infected with AlexaFluor488-labeled C. albicans or C. parapsilosis (MOI 5) for 5, 
15, 30, 60 and 90 min; phagocytosis was determined by flow cytometry. Results (mean ± SEM) are pooled data 
from at least three (a,b,e–h) or representative of two (c,d) independent experiments. Ctrl, control (medium-
treated cells); Ca, C. albicans; Cp, C. parapsilosis. *p < 0.05, **p < 0.01, ***p < 0.001 (compared to control) as 
determined by paired t-test.
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4 h stimulation with C. parapsilosis, despite that pro-IL-1β was significantly upregulated in these cells (Fig. 4c,d). 
These results suggest that although C. parapsilosis induces a weaker first signal than C. albicans, the delayed 
induction of the IL-1β secretion cannot be attributed solely to the inefficient production of pro-IL-1β .
Next, we wanted to examine the role of signal 2 in inflammasome activation by C. parapsilosis. Despite the 
fact that the role of ROS production in inflammasome activation is controversial, we were curious whether 
C. parapsilosis is able to induce ROS accumulation in THP-1 cells. We found that C. parapsilosis was not able to 
induce ROS generation in the first 4 hours of infection, while C. albicans induced a significant increase in the 
level of ROS (Fig. 4e). However, C. parapsilosis induced the generation of ROS after 12 h incubation (Fig. S1f). 
C. albicans-mediated NLRP3 inflammasome activation has also been associated with the endocytic ability of mac-
rophages26. Indeed, we found that inhibition of phagocytosis with cytochalasin D diminished IL-1β production 
in THP-1 macrophages following 4 h stimulation with C. albicans (Fig. 4f). As C. parapsilosis does not induce the 
secretion of IL-1β after 4 h, and longer incubations in the presence of cytochalasin D resulted in massive cell lysis 
(data not shown), we could not directly assess the role of phagocytosis in C. parapsilosis-induced inflammasome 
activation. However, we evaluated the degree of phagosomal disruption by measurement of lysosomal cathepsin 
B release and found that C. albicans induced considerably higher cathepsin B release in THP-1 cells after 4 hours 
compared to C. parapsilosis (Fig. 4g). Also, we examined the kinetics of the phagocytosis of C. parapsilosis and 
C. albicans and found that C. parapsilosis cells were phagocytosed significantly more slowly by THP-1 macrophages 
than C. albicans cells (Fig. 4h). Taken together, our results suggest that the lower rate of phagocytosis and ROS pro-
duction might be responsible for delayed inflammasome activation following C. parapsilosis stimulation.
C. parapsilosis induces ASC- and NLRP3-dependent cell death in human macrophages. As 
inflammasome activation is strongly connected to cell death, we also examined whether C. parapsilosis could 
induce pyroptosis in macrophages. We found that ASC deficient THP-1 macrophages showed significantly lower 
LDH-release upon stimulation with C. parapsilosis or C. albicans compared to control cells, indicating that both 
species induce ASC-dependent cell death in host cells (Fig. 5a). Also, addition of glycine reduced the amount of 
secreted LDH in control cells in response to both C. parapsilosis and C. albicans infection, confirming that both 
species induce pyroptosis in macrophages (Fig. 5b). We also examined the extent of cell lysis in the presence 
of pan-caspase inhibitor, and found that while it did not affect the release of LDH after 24 h incubation, the 
inhibitor reduced the amount of LDH after 16 h stimulation in case of both C. parapsilosis and C. albicans infec-
tion (Fig. 5c). Interestingly, however, while macrophage lysis was also reduced in NLRP3 deficient cells upon C. 
Figure 5. C. parapsilosis induces ASC- and NLRP3-dependent cell death in human macrophages. THP-1 
macrophages (control as well as ASC-deficient or NLRP3-deficient, where indicated) were stimulated with C. 
parapsilosis (MOI 5) or C. albicans (MOI 0.04) for 24 h (a,b,d) or for 16 and 24 h (c) and cell lysis was assessed 
by LDH assay. LDH release is expressed as % of positive control. (b,c) THP-1 macrophages were stimulated with 
Candida spp. in the presence of pyroptosis inhibitor glycine (5 mM; b) or pan-caspase inhibitor Z-VAD-FMK 
(10 μ M; c). Results (mean ± SEM) are pooled data from at least three independent experiments. Ca, C. albicans; 
Cp, C. parapsilosis. *p < 0.05, ****p < 0.0001 (compared to control) as determined by paired t-test.
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parapsilosis infection, LDH release was independent of NLRP3 in C. albicans-stimulated cells (Fig. 5d). These 
results suggest that different cell death pathways may be activated in host cells in response to C. parapsilosis and 
C. albicans infection.
Discussion
In this study, we investigated the molecular mechanisms of inflammasome activation in human macrophages in 
response to C. parapsilosis. We showed that C. parapsilosis is able to induce inflammasome activation with sub-
sequent IL-1β and IL-18 release in both human THP-1 macrophages and MDMs, but the induction of cytokine 
secretion requires a relatively long incubation period and large fungal inoculum. As a control, we also performed 
cell stimulations with C. albicans and found that a 100-fold lower dose of C. albicans cells was sufficient to induce 
IL-1β and IL-18 levels that were comparable to that induced by C. parapsilosis. A crucial difference between these 
two species is that while C. albicans produces hyphae, C. parapsilosis is only able to develop pseudohyphae27. It 
has been previously thought that hyphae formation is essential for inflammasome activation by C. albicans26; 
however, several non-filamenting mutants are also able to induce IL-1β production28. Our results confirm that 
the presence of true hyphae is not a prerequisite for the activation of the inflammasome by Candida spp. Next, 
we examined the molecular pathways involved in inflammasome activation induced by C. parapsilosis, focus-
ing on the production of IL-1β . Generally, inflammasome priming can be initiated by any receptor that acti-
vates NFκ B, such as TLRs, IL-1R or TNFR29. C. albicans can be recognized by several different PRRs that induce 
NFκ B activation and subsequent pro-inflammatory cytokine production (reviewed in ref. 30). In macrophages, 
Dectin-1 and TLR2 are crucial for IL-1β synthesis in response to C. albicans14, but it is important to note that 
the role of PRRs in C. albicans-induced IL-1β production is still not completely elucidated. The PRRs mediat-
ing C. parapsilosis-induced IL-1β response in macrophages have not been identified yet. Here we found that in 
THP-1 macrophages, IL-1β production induced by either C. parapsilosis or C. albicans was dependent on TLR4. 
Interestingly however, pro-IL-1β accumulation was only slightly affected by TLR4 inhibition, suggesting a role for 
the receptor in inflammasome priming or activation rather than in the induction of pro-IL-1β synthesis. TLR4 
plays an important role in the non-transcriptional priming of NLRP331; it is tempting to speculate that the recep-
tor plays a similar role in our system as well.
The tyrosine kinase Syk plays an important role in the signalling of C-type lectin receptors (such as Dectin-1, 
Dectin-2 or Mincle) and it is necessary for both pro-IL-1β up-regulation and caspase-1 activation in response to 
C. albicans25. Indeed, we found that Syk inhibition resulted in a profound reduction in pro-IL-1β and secreted 
IL-1β levels stimulated by C. parapsilosis and C. albicans. Interestingly, pro-IL-1β production was more strongly 
affected by Syk inhibition in response to C. albicans, suggesting a possible difference in the triggered signalling 
pathways leading to pro-IL-1β accumulation in C. albicans and C. parapsilosis infection.
We also found that IL-1β production was significantly reduced in THP-1 cells in the presence of caspase-8 
inhibitor. Caspase-8 affects the production of IL-1β in at least two ways: on the one hand, it can be recruited to the 
CARD9/BCL10/MALT1 signaling complex and directly cleave pro-IL-1β upon Syk activation; on the other hand, 
it is required for the assembly of NLRP3 inflammasome complex and the activation of caspase-132. However, we 
found that IL-1β production was completely abolished in NLRP3-deficient THP-1 cells, suggesting that in our 
experimental system, caspase-8 is required for the NLRP3-dependent, rather than the direct processing of IL-1β . 
At the same time, these results also indicate that inflammasome independent, alternative mechanisms33 do not 
play a role in IL-1β processing in this experimental system.
Interestingly, we found that in contrast to C. albicans, C. parapsilosis was not able to induce IL-1β and IL-18 
production after short (4 h) incubation, even when a large inoculum was used. In theory, this could be caused by 
either the lack of signal 1 or signal 2 during early infection. While C. albicans further increased the accumula-
tion of pro-IL-1β in THP-1 macrophages after 4 h, pro-IL-β up-regulation in response to C. parapsilosis was not 
detected in THP-1 cells at this time point, suggesting a difference in signal 1. However, stimulation with C. par-
apsilosis induced a robust increase in pro-IL-1β levels in MDMs. These results, together with the finding that C. 
parapsilosis was not able to induce the secretion of IL-1β after 4 h in THP-1 cells despite pro-IL-1β being already 
up-regulated suggests that either (A) C. parapsilosis cannot induce the post-translational modifications in NLRP3 
necessary for inflammasome activation, (B) signal 2 is delayed in response to C. parapsilosis infection.
The role of ROS production in inflammasome activation is still a matter of intense debate. While some 
authors have found that inhibition of the NADPH-oxidase-dependent ROS system diminished caspase-1 acti-
vation in response to asbestos or C. albicans25,34, others have demonstrated that inflammasome activation is 
in fact increased in ROS-deficient monocytes isolated from patients with chronic granulomatous disease35,36. 
Here we found that C. albicans but not C. parapsilosis induced ROS accumulation in THP-1 cells after 4 hours 
of co-incubation. Whether this is directly associated with caspase-1 activation needs to be further investigated 
in the future. We also found that C. parapsilosis triggered significantly lower phagosomal cathepsin B release 
after 4 hours compared to C. albicans. These results suggest that the delay in IL-1β production may be caused 
by the lack of signal 2 during early C. parapsilosis infection. The requirement of phagocytosis for inflammasome 
activation by C. albicans was confirmed by our results showing that inhibition of phagocytosis by cytochalasin D 
abolished IL-1β production in response to C. albicans infection. In line with the low cathepsin B release, we found 
that C. parapsilosis was phagocytosed significantly more slowly by THP-1 macrophages than C. albicans. These 
results are in agreement with our previous findings that J774 macrophages phagocytosed C. parapsilosis cells 
much slower compared to C. albicans4. Although the specific PRRs responsible for the induction of C. parapsilosis 
phagocytosis remain to be identified, these results suggest that the differential recognition of the two Candida 
species results in different phagocytosis kinetics and, consequently, affect the extent of inflammasome activation.
Importantly, modifications in the fungal cell wall upon phagocytosis are crucial for the induction of pyrop-
tosis by C. albicans37. As pyroptosis is strongly connected to inflammasome activation, it is likely that cell wall 
modifications in the phagosome influence the activation of the inflammasome as well. To investigate if C. 
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parapsilosis is able to induce pyroptosis in macrophages, we assessed the LDH release of ASC-deficient THP-1 
macrophages upon C. parapsilosis and C. albicans stimulation. We found that cell lysis induced by C. parapsi-
losis was significantly reduced in ASC-deficient THP-1 cells, indicating that this species is also able to induce 
pyroptotic cell death. Additionally, C. parapsilosis-induced LDH release could be inhibited by glycine, a pyrop-
tosis inhibitor19. Interestingly, we also found that while C. parapsilosis-induced cell death was also dependent on 
NLRP3, C. albicans induced similar LDH release in both control and NLRP3-deficient cells. Although C. albi-
cans induces ASC- and NLRP3-dependent pyroptosis in mouse bone marrow-derived macrophages19, cell death 
pathways induced by this pathogen in human macrophages have not been explored yet. Our results suggest that 
NLRP3-independent cell death pathways may also be triggered by C. albicans.
Besides IL-1β , IL-1α is another member of the IL-1 cytokine family that has potent pro-inflammatory func-
tions38. The pro-form of the cytokine is quickly released from dying cells and can act as an alarmin39. IL-1α 
plays a non-redundant role in host defence against C. albicans40. As IL-1α can directly induce the production 
of pro-IL-1β 41, we hypothesized that another reason for the delayed induction of IL-1β in response to C. par-
apsilosis might be the lack of a positive feedback loop generated by IL-1α . However, we found that IL-1α could 
not be detected in cell culture supernatants following the stimulation of THP-1 cells (for 4 h or 24 h) with either 
C. albicans or C. parapsilosis (data not shown). These results argue against the role of IL-1α in C. albicans- and 
C. parapsilosis-mediated inflammasome activation in THP-1 macrophages. However, IL-1α secretion was 
induced in human MDMs in response to both C. parapsilosis and C. albicans after 24 h (Fig. S1g); therefore, we 
cannot exclude the possibility that this cytokine has a role in Candida-induced inflammasome activation in pri-
mary macrophages.
It is a very interesting question whether C. parapsilosis is able to inhibit the activation of caspase-1 in host 
cells. Many bacterial pathogens have been shown to inhibit inflammasome activation through different mech-
anisms42, but a similar strategy in the case of fungi has not been described yet. Either C. parapsilosis is able to 
inhibit the activation of caspase-1, or the delay in IL-1β production is caused merely by the lack of signal 2, 
either of which may have very important in vivo consequences. The inflammasome plays an essential role in the 
induction of appropriate Th1 and Th17 responses during C. albicans infection in vivo18. While IL-1β is necessary 
for the differentiation of Th17 cells43, that play a central role during fungal infection by mediating neutrophil 
responses22, IL-18 enhances the IFNγ production of Th1 lymphocytes23. Th1 cells also play a protective role dur-
ing fungal infection, by enhancing phagocytosis through the production of IFNγ 44. We have previously shown 
that C. parapsilosis induces more IL-10, and significantly less IFNγ , IL-17 and IL-22 in human PBMCs compared 
to C. albicans, indicating a bias in Th response5. In light of our current findings, it is likely that the low extent of 
inflammasome activation is responsible for decreased Th1/Th17 differentiation during C. parapsilosis infection. 
In vivo experiments can confirm this hypothesis in the future. Furthermore, the low IL-1β production during 
C. parapsilosis infection may also (at least partially) explain the increased susceptibility of newborns to C. par-
apsilosis infection. It is conceivable that in immunocompetent individuals, the low level of IL-1β does not cause 
any problems as other effector mechanisms can keep the infection under control. However, neonates have an 
immature innate immune system45,46; therefore, it is possible that the lack of efficient innate defences coupled 
with the lack of potent Th1/Th17 responses may lead to the free proliferation of fungal cells and ultimately serious 
infection.
In conclusion, we have shown that C. parapsilosis is able to induce NLRP3 inflammasome activation in human 
macrophages, but only after longer incubation and when fungal cells are present in sufficiently high numbers. 
Although we identified several molecules that play an important role in IL-1β production stimulated by C. par-
apsilosis, the exact mechanisms of inflammasome activation are to be examined by future studies. Furthermore, in 
vivo experiments with IL-1β deficient mice in the future may provide further insight about the role of inflammas-
ome activation in host defence during C. parapsilosis infection. Importantly, the results generated in this study 
as well as those of future projects might get us closer to the understanding of inflammatory responses during 
fungal infections, that may ultimately contribute to the development of more effective immune-based antifungal 
therapies.
Methods
Ethics statement. For isolation of PBMC blood was taken from healthy donors. This procedure and the 
respective consent documents were approved by the Institutional Human Medical Biological Research Ethics 
Committee of the University of Szeged. All healthy donors provided written informed consent. All experiments, 
were performed in accordance with guidelines and regulations of the Ethics Committee of University of Szeged, 
and experimental protocols were approved by this institutional committee.
Candida strains. C. parapsilosis GA1 (SZMC 8110)47, CLIB214 (SZMC 1560)48, 75 (SZMC 8002), 79 (SZMC 
1596), 82 (SZMC 8111) and C. albicans SC5314 (SZMC 1523)49, L43 (SZMC 22800) and L44 (SZMC 22801) wild 
type strains were used in this study. Unless otherwise indicated, experiments were performed using the C. par-
apsilosis GA1 and the C. albicans SC5314 wild type strains. Candida cells were grown overnight at 30 °C in liquid 
YPD medium (1% yeast extract, 2% bactopepton, and 2% glucose). Prior to experiments, cells were harvested by 
centrifugation, washed twice with PBS (phosphate-buffered saline; 137 mM NaCl, 2.7 mM KCl, 10 mM Na2HPO4, 
2 mM KH2PO4; pH 7.4) and counted using a hemocytometer. Unless otherwise indicated, all stimulations were 
performed using live microorganisms. When necessary, Candida cells were heat killed for 30 min at 100 °C.
Differentiation and stimulation of THP-1 macrophages. THP-1 cells (control, Sigma-Aldrich; 
ASC- and NLRP3-deficient, InvivoGen) were cultured in RPMI 1640 medium (Lonza) supplemented with 10% 
heat-inactivated FBS (Lonza), 100 U/ml penicillin (Sigma-Aldrich), 100 mg/ml streptomycin (Sigma-Aldrich) 
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and 0.05 μ M 2-mercaptoethanol. To induce macrophage differentiation, THP-1 cells were plated in 24-well tissue 
culture plates at a density of 5 × 105 cells/well (in 500 μ L medium) and treated with 10 nM phorbol myristate ace-
tate (PMA, Sigma) for 24 h. Following PMA-treatment, cells demonstrated macrophage-like morphology, as pre-
viously described50. THP-1 macrophages were stimulated with C. parapsilosis or C. albicans in PMA-free medium 
(500 μ L/well). When inhibitors were used, THP-1 macrophages were pre-incubated with the specific reagent or 
appropriate vehicle for 1 h (in 400 μ L medium) and Candida cells were subsequently added in a 100 μ L-volume. 
After the incubation period, supernatants were collected and stored at − 20 °C until use.
Differentiation and stimulation of primary MDMs. Human peripheral blood mononuclear cells 
were isolated from buffy coats of healthy donors using Ficoll Paque PLUS (GE Healthcare) in accordance with 
the instructions of the manufacturer. MDM differentiation was performed as previously described, with the 
exception that 24-well tissue culture plates were used24. Briefly, monocytes were isolated by plastic adherence 
and cultured in serum-free X-VIVO 15 medium (Lonza) supplemented with 100 U/mL penicillin, 100 mg/mL 
streptomycin and 10 ng/mL recombinant human granulocyte-macrophage colony-stimulating factor (GM-CSF, 
Sigma-Aldrich) for 7 days. The final density of MDM cultures was approx. 3.5 × 105 cells/well. Differentiated 
MDMs were counted and stimulated with C. parapsilosis or C. albicans suspended in GM-CSF-free X-VIVO 15 
medium (500 μ L/well). In certain experiments, MDMs were pre-incubated with various inhibitors (or an appro-
priate vehicle) for 1 h in 400 μ L medium, and 100 μ L medium containing the appropriate amount of Candida 
cells was subsequently added to the wells. After the incubation period, supernatants were collected and stored 
at − 20 °C until cytokine analysis.
Reagents. Syk inhibitor (ER 27319 maleate), TLR2 inhibitor (human TLR2 mAb, clone 383936), isotype 
control for TLR2 mAb (mouse IgG2B, clone 20116), pan-caspase inhibitor (Z-VAD-FMK), caspase-8 inhibi-
tor (Z-IETD-FMK), NADPH-oxidase inhibitor (apocynin) and phagocytosis inhibitor (cytochalasin D) were 
purchased from R&D Systems. TLR4 inhibitor (CLI-095) was from Invivogen, IRAK-1/4 inhibitor from EMD 
Millipore, glycine from Sigma-Aldrich. All inhibitors were used at concentrations indicated in the figure legends. 
All reagents were reconstituted in sterile dimethyl sulfoxide except for the antibodies that were dissolved in PBS 
and glycine that was dissolved in distilled water.
Cytokine measurements. The concentrations of IL-1β , IL-18 and IL-1α in cell culture supernatants were 
determined by commercial ELISA kits (MBL for IL-18 and R&D Systems for IL-1α and - β ) in accordance with 
the manufacturer’s instructions. The concentration of pro-IL-1β was measured by ELISA following the lysis of 
macrophages by repeated freeze-thaw cycles, as previously described25.
Detection of caspase-1 activity by flow cytometry. Caspase-1 activity was detected by using the 
FAM-FLICA Caspase-1 Assay Kit (ImmunoChemistry Technologies). THP-1 macrophages or MDMs were stim-
ulated with C. parapsilosis or C. albicans for 24 h in 12-well culture plates (106 cells/well). Supernatants were 
removed, cells were washed with PBS, gently suspended by pipetting in 2 mL PBS, transferred to 2 mL micro-
centrifuge tubes and harvested by centrifugation. Subsequently, macrophages were resuspended in 200 μ L RPMI 
1640 medium and incubated with 30x FLICA solution (6.6 μ L/sample) for 60 min at 37 °C in the dark. Following 
staining, cells were washed twice with 2 mL wash buffer (included in the kit) and resuspended in 300 μ L wash 
buffer. Samples were measured using a FACSCalibur instrument (BD Biosciences) and analyzed using the FlowJo 
v10 software.
Measurement of ROS production. DCFDA (2′ ,7′ –dichlorofluorescein diacetate) - Cellular Reactive 
Oxygen Species Detection Assay Kit (Abcam) was used to detect intracellular ROS production. THP-1 cell were 
differentiated in black, 96-well cell culture plates (105 cells/well). Macrophages were washed with PBS and 25 μ M 
DCFDA substrate was added to the samples. After incubation for 45 min at 37 °C, cells were washed with PBS, and 
Candida cells (suspended in PBS) were added to the wells (MOI 1). Control wells were treated with sterile PBS 
buffer only. Fluorescence was detected at 20-min intervals by a FLUOstar OPTIMA Microplate Reader (BMG 
Labtech). Data were expressed as fold change in fluorescence intensity relative to unstimulated cells.
Detection of cathepsin B release. Intracellular cathepsin B activity was determined by using the 
Cathepsin B Activity Assay Kit (Abcam). THP-1 macrophages were stimulated with C. parapsilosis or C. albicans 
(MOI 1) for 4 h. Subsequently, supernatants were removed, cells were washed twice with PBS and suspended to 
a single cell suspension by pipetting. Cell numbers were normalized and macrophages were lysed according to 
the manufacturer’s instructions. Samples were centrifuged, and 50 μ L supernatants were transferred into black, 
96-well plates. Ac-RR-AFC substrate was added to the wells as instructed by the manufacturer and plates were 
incubated for 2 h at 37 °C in the dark. Fluorescence was detected by a FLUOstar OPTIMA Microplate Reader 
(BMG Labtech). Fluorescence intensity (correlating with the amount of cathepsin B released from lysosomes) was 
expressed as fold change compared to that detected in unstimulated cells.
Phagocytosis assay. Phagocytic activity was examined as previously described51, with minor modifications. 
Candida cells were labelled with AlexaFluor488 carboxylic acid, succinimidyl ester (Invitrogen) and co-cultured 
with THP-1 macrophages at MOI 5 for 5, 15, 30, 60 or 90 min in 24-well tissue culture plates. After the incubation 
period, THP-1 cells were washed two times with PBS, gently suspended to a single cell suspension by pipet-
ting, transferred to 2 mL microcentrifuge tubes, harvested by centrifugation and resuspended in 300 μ L PBS. To 
detect the ratio of Candida cells adhered to host cells but not phagocytosed, experiments were also performed in 
the presence of 2.5 μ M cytochalasin D. As the number of positive events was negligible in samples treated with 
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cytochalasin D, we defined AlexaFluor 488+ macrophages as the phagocytosing cell population. Samples were 
measured using a FACSCalibur instrument (BD Biosciences) and analysed using the FlowJo v10 software.
Measurement of LDH activity. LDH activity in cell culture supernatants was determined by using the 
LDH cytotoxicity detection kit (Takara) according to the manufacturer’s instructions. Cytotoxicity was calculated 
as follows: cytotoxicity (%) = (ODexperimental value/ODpositive control) × 100 − (OD unstimulated control/ODpositive control) × 100. 
The supernatant of cells treated with 1% Triton X-100 served as positive control.
Western blot. Monolayers of THP-1 (3 × 106 cells/well) and primary human macrophages were infected with 
Candida in 6 well plates in 1.2 ml serum-free RPMI 1640 medium for 4 h or 24 h. Supernatants were collected and 
macrophages were washed twice with PBS. Subsequently, macrophages were lysed in 80 μ L lysis buffer (50 mM 
Tris, 2 mM EDTA, 50 mM NaCl) supplemented with 2 mM phenylmethylsulfonyl fluoride (PMSF), 0.8 μ L pro-
tease inhibitor cocktail and 1 mM sodium orthovanadate (all from Santa Cruz Biotechnology) by 5 freeze-thaw 
cycles. Cell culture supernatants from two wells per treatment were pooled and concentrated with Amicon® 
Ultra-2 3 K Centrifugal Filter Devices. 20 μ l of supernatant concentrates or cell lysates containing 20 μ g of total 
protein were separated by NuPAGE™ Novex™ 4–12% Bis-Tris Protein Gels in 1x NuPAGE® MES SDS Running 
Buffer and transferred onto PVDF membranes using the iBlot® Dry Blotting System (Invitrogen) and respec-
tive transfer stacks. Membranes were blocked in 5% BSA-TBST (5 mM Tris, 15 mM NaCl, 0.05% Tween-20, 5% 
BSA, pH 7.4) for 1 h, and then washed 3 times for 5 min with TBST. Blots were incubated with rabbit polyclonal 
anti-IL-1β antibody (sc-7884, Santa Cruz Biotechnology, dilution 1:200) and (in the case of cell lysates) rabbit 
polyclonal anti-α -actin antibody (sc-1616, Santa Cruz Biotechnology, dilution 1:200) in 1% BSA-TBST overnight 
at 4 °C. Blots were washed 3 times for 5 min with TBST. Membranes were incubated with HRP-conjugated goat 
anti-rabbit IgG secondary antibody (sc-2030-R, Santa Cruz Biotechnology, dilution 1:5000) for 1 h followed by 
washing 3 times in TBST. Membranes were then covered with a layer of Chemiluminescence Luminol Reagent 
(sc-2048) for 1 min and detected with the ECL (enhanced chemiluminescence) method.
Statistical analysis. Statistical analysis was performed using the GraphPad Prism 6 software. All experi-
ments were performed at least twice. Paired or unpaired t-test was used to establish statistical significance (see 
figure legends for details) and differences between groups were considered significant at p values of < 0.05.
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